DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of

Meng-Jie Wang1,2, Yu Xia3,4, Qing-Lei Gao5,6

  • 1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

PubMed

Insights

DNA damage impacts tumor development and the immune microenvironment. Understanding DNA damage response and cytokines is crucial for developing effective cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • DNA damage is a fundamental process in tumorigenesis and tumor progression.
  • Tumor-intrinsic DNA damage can trigger cellular stress responses that shape the tumor immune microenvironment (TIME).
  • Key signaling pathways like cGAS-STING and ATM/ATR are activated by DNA damage, influencing cytokine secretion.

Purpose of the Study:

  • To comprehensively review the intricate relationship between DNA damage response and cytokines within tumors.
  • To elucidate the dual immunoregulatory roles of these cytokines in the tumor immune microenvironment.
  • To summarize current clinical trials targeting DNA damage-related pathways and cytokines and offer future perspectives.

Main Methods:

  • Literature review of studies on DNA damage, cytokines, and the tumor immune microenvironment.
  • Analysis of signaling pathways activated by DNA damage, including cGAS-STING and ATM/ATR.
  • Compilation of data from clinical trials investigating targeted therapies.

Main Results:

  • DNA damage significantly influences the tumor immune microenvironment through stress responses and cytokine signaling.
  • Activated pathways like cGAS-STING and ATM/ATR mediate the secretion of diverse cytokines with varied immune functions.
  • Cytokines exhibit dual roles in regulating anti-tumor immunity, impacting therapeutic strategies.

Conclusions:

  • A deeper understanding of how DNA damage and cytokines reshape the TIME is essential for advancing cancer therapy.
  • Targeting DNA damage response pathways and associated cytokines holds promise for novel immunotherapeutic approaches.
  • Emerging technologies may offer new avenues for exploiting the DNA damage-cytokine axis in cancer treatment.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K